Co-Authors
This is a "connection" page, showing publications co-authored by Richard Meenan and Beverly Green.
Connection Strength
4.471
-
Colorectal cancer screening: The costs and benefits of getting to 80% in every community. Cancer. 2020 09 15; 126(18):4110-4113.
Score: 0.754
-
Costs of Two Health Insurance Plan Programs to Mail Fecal Immunochemical Tests to Medicare and Medicaid Plan Members. Popul Health Manag. 2021 04; 24(2):255-265.
Score: 0.751
-
A cost-effectiveness analysis of a colorectal cancer screening program in safety net clinics. Prev Med. 2019 Mar; 120:119-125.
Score: 0.681
-
An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015 Jun; 48(6):714-21.
Score: 0.528
-
Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening. JAMA Netw Open. 2023 03 01; 6(3):e234052.
Score: 0.226
-
Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models. Cancer. 2022 Jan 15; 128(2):410-418.
Score: 0.205
-
A Centralized Program with Stepped Support Increases Adherence to Colorectal Cancer Screening Over 9 Years: a Randomized Trial. J Gen Intern Med. 2021 May 28.
Score: 0.200
-
Financial Incentives to Increase Colorectal Cancer Screening Uptake and Decrease Disparities: A Randomized Clinical Trial. JAMA Netw Open. 2019 07 03; 2(7):e196570.
Score: 0.175
-
A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer. 2017 Nov 15; 123(22):4472-4480.
Score: 0.153
-
Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer. 2016 Jan 15; 122(2):312-21.
Score: 0.136
-
Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med. 2014 Nov-Dec; 27(6):789-95.
Score: 0.127
-
Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014 Jul; 38(2):344-9.
Score: 0.124
-
An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):301-11.
Score: 0.113
-
Nonparticipation in a population-based trial to increase colorectal cancer screening. Am J Prev Med. 2012 Apr; 42(4):390-7.
Score: 0.106
-
Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010 Nov; 31(6):589-603.
Score: 0.094
-
Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial. Contemp Clin Trials. 2022 11; 122:106960.
Score: 0.055
-
Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial. Cancer Med. 2018 Sep; 7(9):4781-4790.
Score: 0.041